Overview
Background
Dr Mollee practices as a consultant haematologist in clinical and laboratory haematology at the Princess Alexandra Hospital and is Associate Professor with the University of Queensland Medical School.
Having trained in Brisbane and Toronto, Dr Mollee has developed an international reputation studying amyloidosis and the plasma cell dyscrasias. He holds appointments with the Medical Scientific Advisory Group of Myeloma Australia, Australian Amyloidosis Network, National Blood Cancer Taskforce and is a member of the AACB Monoclonal Gammopathy Working Group and the International Kidney & Monoclonal Gammopathy Research Group. He is a past Chairman of the Australasian Leukaemia and Lymphoma Group (ALLG) and current Chair of the Australian Amyloidosis Network. He heads the Myeloma Service as well as the Queensland Amyloidosis Centre which runs one of the few clinics in Australia dedicated exclusively to the care of patients with amyloidosis.
Availability
- Associate Professor Peter Mollee is:
- Available for supervision
Qualifications
- Masters (Coursework) of Medical Science, University of Newcastle
- Royal Australasian College of Physicians, Royal Australasian College of Physicians
- Royal College of Pathologists of Australasia, Royal College of Pathologists of Australasia
Research impacts
The research of the Queensland Amyloidosis Centre aims to improved the diagnosis, monitoring and therapy of all types of amyloidosis. The Centre, in collaboration with Pathology Queensland and the Translational Research Institute, developed laser capture macrodisscution and tandem mass spectrometry analysis to accurately diagnosis the type of amyloidosis that patients have and have introuduced this assay into the clinical laboratory. Research to improve the diagnosis and monitoring of this rare disease has also assessed immunoglobulin free light chain assays, bone scintigraphy and novel radionuclide PET tracers. The Queensland Amyloidosis Centre maintains an active clinical trial program in amyloidosis therapies including both investigator-initiated and commercial studies.
Works
Search Professor Peter Mollee’s works on UQ eSpace
2017
Conference Publication
First Australian registry of patients with wild type cardiac amyloidosis (ATTRwt): Queensland experience
Burrage, M., Korczyk, D. and Mollee, P. (2017). First Australian registry of patients with wild type cardiac amyloidosis (ATTRwt): Queensland experience. ESC Congress 2017, Barcelona, Spain, 26-30 August 2017. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/eurheartj/ehx502.1955
2017
Journal Article
Monitoring of light chain myeloma - time for a change
Mollee, Peter and Tate, Jill (2017). Monitoring of light chain myeloma - time for a change. British Journal of Haematology, 178 (2), 177-178. doi: 10.1111/bjh.14752
2017
Journal Article
Peripherally InSerted CEntral catheter dressing and securement in patients with cancer: the PISCES trial. Protocol for a 2x2 factorial, superiority randomised controlled trial
Rickard, Claire M., Marsh, Nicole M., Webster, Joan, Gavin, Nicole C., Chan, Raymond J., McCarthy, Alexandra L., Mollee, Peter, Ullman, Amanda J., Kleidon, Tricia, Chopra, Vineet, Zhang, Li, McGrail, Matthew R., Larsen, Emily, Abu Choudhury, Md, Keogh, Samantha, Alexandrou, Evan, McMillan, David J., Mervin, Merehau Cindy, Paterson, David L., Cooke, Marie, Ray-Barruel, Gillian, Castillo, Maria Isabel, Hallahan, Andrew, Corley, Amanda and Playford, E. Geoffrey (2017). Peripherally InSerted CEntral catheter dressing and securement in patients with cancer: the PISCES trial. Protocol for a 2x2 factorial, superiority randomised controlled trial. BMJ Open, 7 (6) e015291, e015291. doi: 10.1136/bmjopen-2016-015291
2017
Journal Article
Using pharmacy management systems for research: survival outcomes for lenalidomide in multiple myeloma in the clinical setting
Sharkey, Megan M., McKavanagh, Daniel, Walpole, Euan, Mollee, Peter and Hollingworth, Samantha A. (2017). Using pharmacy management systems for research: survival outcomes for lenalidomide in multiple myeloma in the clinical setting. International Journal of Clinical Pharmacy, 39 (4), 836-843. doi: 10.1007/s11096-017-0480-0
2017
Journal Article
Mass spectrometry analysis for amyloidosis typing - is the future bright for its clinical implementation?
Hill, Michelle M. and Mollee, Peter N. (2017). Mass spectrometry analysis for amyloidosis typing - is the future bright for its clinical implementation?. Expert Review of Proteomics, 14 (7), 565-566. doi: 10.1080/14789450.2017.1322905
2017
Journal Article
Partial response after induction chemotherapy has clinical relevance in acute myeloid leukaemia
Fleming, Shaun, Ong, Doen Ming, Jackson, Kathryn, Avery, Sharon, Mollee, Peter, Marlton, Paula, Kennedy, Glen and Wei, Andrew H (2017). Partial response after induction chemotherapy has clinical relevance in acute myeloid leukaemia. British Journal of Haematology, 177 (2), 328-330. doi: 10.1111/bjh.14063
2017
Journal Article
Malabsorption secondary to gout-induced amyloidosis
Azzam, Ali, Balasubramaniam, Renuka, Safa, Shahram, McIvor, Carolyn and Mollee, Peter (2017). Malabsorption secondary to gout-induced amyloidosis. ACG Case Reports Journal, 4 (1), e32. doi: 10.14309/crj.2017.32
2017
Journal Article
Response to rituximab induction is a predictive marker in B-cell post-transplant lymphoproliferative disorder and allows successful stratification into rituximab or r-chop consolidation in an international, prospective, multicenter Phase II trial
Trappe, Ralf U., Dierickx, Daan, Zimmermann, Heiner, Morschhauser, Franck, Mollee, Peter, Zaucha, Jan M., Dreyling, Martin H., Duhrsen, Ulrich, Reinke, Petra, Verhoef, Gregor, Subklewe, Marion, Huttmann, Andreas, Tousseyn, Thomas, Salles, Gilles, Kliem, Volker, Hauser, Ingeborg A., Tarella, Corrado, Neste, Eric Van Den, Gheysens, Olivier, Anagnostopoulos, Ioannis, Leblond, Veronique, Riess, Hanno and Choquet, Sylvain (2017). Response to rituximab induction is a predictive marker in B-cell post-transplant lymphoproliferative disorder and allows successful stratification into rituximab or r-chop consolidation in an international, prospective, multicenter Phase II trial. Journal of Clinical Oncology, 35 (5), 536-543. doi: 10.1200/JCO.2016.69.3564
2017
Conference Publication
Combination bone marrow imaging using PET-MRI in plasma cell dyscrasias: correlation with prognostic laboratory values and clinicopathological diagnosis
Tate, Courtney, Miles, Kenneth and Mollee, Peter (2017). Combination bone marrow imaging using PET-MRI in plasma cell dyscrasias: correlation with prognostic laboratory values and clinicopathological diagnosis. 16th International Myeloma Workshop, New Delhi, India, 1-4 March 2017. Elsevier BV. doi: 10.1016/j.clml.2017.03.081
2017
Journal Article
Monoclonal gammopathy of renal significance triggering atypical haemolytic uraemic syndrome : MGRS triggering aHUS
Mahmood, Usman, Isbel, Nicole, Mollee, Peter, Mallett, Andrew, Govindarajulu, Sridevi and Francis, Ross (2017). Monoclonal gammopathy of renal significance triggering atypical haemolytic uraemic syndrome : MGRS triggering aHUS. Nephrology, 22 (S1), 15-17. doi: 10.1111/nep.12934
2017
Journal Article
Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group
Talaulikar, Dipti, Tam, Constantine S., Joshua, Douglas, Ho, Joy Phoebe, Szer, Jeff, Quach, Hang, Spencer, Andrew, Harrison, Simon, Mollee, Peter, Roberts, Andrew W., Horvath, Noemi, Lee, Cindy, Zannettino, Andrew, Brown, Ross, Augustson, Bradley, Jaksic, Wilfrid, Gibson, John, Kalff, Anna, Johnston, Anna, Trotman, Judith, Kalro, Akash, Grigoriadis, George, Ward, Chris and Prince, H. Miles (2017). Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group. Internal Medicine Journal, 47 (1), 35-49. doi: 10.1111/imj.13311
2017
Conference Publication
Catheter-Associated Bloodstream Infections (CA-BSI) in Adults with Cancer: A Prospective Randomized Controlled Trial
Mollee, Peter, Okano, Satomi, Looke, David, Kennedy, Glen, Harper, John, Clouston, John, Van Kuilenburg, Rosita, Geary, Alanna, Joubert, Warren, Eastgate, Melissa and Jones, Mark (2017). Catheter-Associated Bloodstream Infections (CA-BSI) in Adults with Cancer: A Prospective Randomized Controlled Trial. In: 59th Annual Meeting of the American-Society-of-Hematology (ASH), Atlanta, GA United States, (). 9-12 December 2017.
2017
Conference Publication
The Effect of Immune Checkpoint Inhibitors in Patients with Concomitant Advanced Melanoma and Chronic Lymphocytic Leukaemia
Tobin, Joshua W. D., Royle, Jane, Mason, Robert, Michael, Millward, Lydia, Warburton, Sandhu, Shahneen, Haydon, Andrew, Long, Georgina, Carlino, Matteo, Smith, Jessica L., Dearden, Helen, Mollee, Peter, Gill, Devinder, Mapp, Sally, Atkinson, Victoria and Keane, Colm (2017). The Effect of Immune Checkpoint Inhibitors in Patients with Concomitant Advanced Melanoma and Chronic Lymphocytic Leukaemia. 59th Annual Meeting of the American-Society-of-Hematology (ASH), Atlanta, GA United States, 9-12 December 2017. Washington, DC United States: American Society of Hematology.
2017
Conference Publication
Evaluation of bortezomib use in Queensland public hospitals for the treatment of multiple myeloma
Walpole, Euan, Mollee, Peter, McPherson, Ian, Loke, Crystal and Hollingworth, Samantha (2017). Evaluation of bortezomib use in Queensland public hospitals for the treatment of multiple myeloma. COSA's 44th Annual Scientific Meeting, Sydney, NSW, Australia, 13-15 November 2017. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12799
2017
Conference Publication
Cardiac amyloid imaging with 18F-florbetaben positron emission tomography: a pilot study
Law, W. Phillip, Wang, William, Moore, Peter, Mollee, Peter and Ng, Arnold (2017). Cardiac amyloid imaging with 18F-florbetaben positron emission tomography: a pilot study. XVth International Symposium on Amyloidosis, Indianapolis, IN, USA, 2014. Abingdon, Oxfordshire, United Kingdom: Taylor & Francis. doi: 10.1080/13506129.2017.1281120
2016
Journal Article
Design and development of the Australian and New Zealand (ANZ) myeloma and related diseases registry
Bergin, Krystal, Moore, Elizabeth, McQuilten, Zoe, Wood, Erica, Augustson, Bradley, Blacklock, Hilary, Ho, Joy, Horvath, Noemi, King, Tracy, McNeil, John, Mollee, Peter, Quach, Hang, Reid, Christopher M., Rosengarten, Brian, Walker, Patricia and Spencer, Andrew (2016). Design and development of the Australian and New Zealand (ANZ) myeloma and related diseases registry. Bmc Medical Research Methodology, 16 (1) 151, 151. doi: 10.1186/s12874-016-0250-z
2016
Journal Article
The utility of 99mTc-DPD scintigraphy in the diagnosis of cardiac amyloidosis: an Australian experience
Moore, Peter T., Burrage, Matthew K., Mackenzie, Emily, Law, W. Philip, Korczyk, Dariusz and Mollee, Peter (2016). The utility of 99mTc-DPD scintigraphy in the diagnosis of cardiac amyloidosis: an Australian experience. Heart, Lung and Circulation, 26 (11), 1183-1190. doi: 10.1016/j.hlc.2016.12.017
2016
Journal Article
Cardiac amyloid imaging with 18F-florbetaben PET: a pilot study
Law, W. Phillip, Wang, William Y. S., Moore, Peter T., Mollee, Peter N. and Ng, Arnold C. T. (2016). Cardiac amyloid imaging with 18F-florbetaben PET: a pilot study. Journal of Nuclear Medicine, 57 (11), 1733-1739. doi: 10.2967/jnumed.115.169870
2016
Journal Article
Implementation and evaluation of amyloidosis subtyping by laser-capture microdissection and tandem mass spectrometry
Mollee, Peter, Boros, Samuel, Loo, Dorothy, Ruelcke, Jayde E., Lakis, Vanessa A., Cao, Kim‑Anh Lê, Renaut, Patricia and Hill, Michelle M. (2016). Implementation and evaluation of amyloidosis subtyping by laser-capture microdissection and tandem mass spectrometry. Clinical Proteomics, 13 (1) 30, 1-6. doi: 10.1186/s12014-016-9133-x
2016
Journal Article
Increased FcγRIIB dominance contributes to the emergence of resistance to therapeutic antibodies in chronic lymphocytic leukaemia patients
Burgess, M., Mapp, S., Mazzieri, R., Cheung, C., Cahmbers, L., Mattarollo, S., Mollee, P., Gill, D. and Saunders, N. A. (2016). Increased FcγRIIB dominance contributes to the emergence of resistance to therapeutic antibodies in chronic lymphocytic leukaemia patients. Oncogene, 36 (17), 2366-2376. doi: 10.1038/onc.2016.387
Supervision
Availability
- Associate Professor Peter Mollee is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Master Philosophy
Novel Radionuclide Tracers for Imaging in Amyloidosis
Principal Advisor
Other advisors: Associate Professor Colm Keane
-
Doctor Philosophy
Addressing frailty in older people with haematological malignancies
Associate Advisor
Other advisors: Associate Professor Emily Gordon, Dr Natasha Reid, Professor Ruth Hubbard
Media
Enquiries
For media enquiries about Associate Professor Peter Mollee's areas of expertise, story ideas and help finding experts, contact our Media team: